15 influential figures in the Asian vaccine industry 9 May 2013 / By jolene / Uncategorized / 0 comments
White Paper provided by Virocyt: An Overview of Virus Quantification Techniques 7 May 2013 / By Tim / Featured on App / 0 comments
3 Exciting Uses of Data for the Future of Vaccine Development 1 May 2013 / By Tim / Featured on App, R&D / 0 comments
Ineffective – HVTN 505 HIV Vaccine Trial Discontinued 26 April 2013 / By Tim / Featured on App, Prophylactic Vaccines, R&D / 2 comments
Nanoparticles take us “on the road” to universal flu vaccine 24 May 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, R&D / 0 comments
Record-Breaking: The 4-Day Pandemic Flu Vaccine 20 May 2013 / By Tim / Featured on App, Flu / 0 comments
250 vaccines in development, including these Phase III cancer vaccines 20 May 2013 / By Tim / Featured on App, Prophylactic Vaccines, R&D / 0 comments
RSV vaccines: developing an effective vaccine – Dr Peter Collins 20 May 2013 / By Tim / Featured Videos, Featured on App / 0 comments
The RSV A nanoparticle vaccine: clinical update – Dr Gregory M. Glenn 20 May 2013 / By Tim / Featured Videos, Featured on App / 0 comments
Lyme Disease vaccine shows promise in Phase I/II trial 16 May 2013 / By Tim / Featured on App, Prophylactic Vaccines, R&D / 0 comments
Media surveillance system analyses public concerns about vaccines 16 May 2013 / By Tim / Featured on App / 1 comment
India announces development of $1 rotavirus vaccine 15 May 2013 / By Tim / Emerging Markets, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 1 comment
Bill and Melinda Gates Foundation – Investing in global health – Kim Bush 14 May 2013 / By Tim / Featured Videos, Featured on App / 0 comments
